Back to Journals » Vascular Health and Risk Management » Volume 12

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab

Total article views   Abstract views HTML views PDF downloads Totals
36,798 Dovepress* 7,560 3,045+ 2,835 10,605
PubMed Central* 0 26,193 5,029 26,193
Totals 7,560 29,238 7,864 36,798
*Since 17 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
32 0 0 0 15 17

View citations on PubMed Central and Google Scholar